share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Storch Gerald L

施貴寶 | 4：持股變動聲明-董事 Storch Gerald L

SEC announcement ·  02/06 08:34
牛牛AI助理已提取核心訊息
Gerald L Storch, associated with Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement.
Gerald L Storch, associated with Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement.
與百時美施貴寶（BMY）有聯繫的傑拉爾德·斯托奇於2024年2月1日參與了該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。
與百時美施貴寶（BMY）有聯繫的傑拉爾德·斯托奇於2024年2月1日參與了該公司股票的交易。公告中未披露交易的具體細節，包括行動類型、狀態、股份數量、股票性質、交易價格和交易後的持股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。